Rare Disease

CRISPR Therapeutics Shares Promising Updates on Zugo-cel in Autoimmune and Oncology Trials

Austin Newman - January 9, 2026
Rare Disease

FDA Approves Amneal’s Denosumab Biosimilars Boncresa and Oziltus

Breast Cancer

Risk-Based Breast Cancer Screening Shows Promise in Major U.S. Study

Dementia

Coya Therapeutics Advances Novel Immunotherapy into Clinical Development for Frontotemporal Dementia

LISTEN TO OUR PODCAST

THE LATEST FROM PATIENT WORTHY

FEATURED

You Are Not Alone: Empowering the Advanced Kidney Cancer Community

Finding Light Through Story – The Power of Ambassadorship in the Endometrial Cancer Community

Read Full Story Here

Read Full Story Here

Rare Disease Clinical Trials Are Essential to Help Uncover Potential Patient Solutions: Spotlight on Classic Congenital Adrenal Hyperplasia (CAH)

UPCOMING EVENTS

SIGN UP FOR OUR NEWSLETTER

SIGN UP »

FOLLOW US ON INSTAGRAM

FOLLOW US ON TIKTOK

FOLLOW US ON FACEBOOK

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
Patient Worthy
50 minutes ago
Patient Worthy

CRISPR technology, ever-advancing, shows promise for the future of both autoimmune and oncological conditions. Read more here:

patientworthy.com/2026/01/09/crispr-therapeutics-shares-promising-updates-on-zugo-cel-in-autoimmu... ... See MoreSee Less

CRISPR technology, ever-advancing, shows promise for the future of both autoimmune and oncological conditions. Read more here: https://patientworthy.com/2026/01/09/crispr-therapeutics-shares-promising-updates-on-zugo-cel-in-autoimmune-and-oncology-trials/
View on Facebook
· Share
Share on Facebook Share on Twitter Share on Linked In Share by Email
View Comments
  • likes 0
  • Shares: 0
  • Comments: 0
Patient Worthy
14 hours ago
Patient Worthy

The FDA has approved two "biosimilars," increasing access to potentially life-saving medication at a potentially more cost-effective rate. Read more here:

patientworthy.com/2026/01/08/fda-approves-amneals-denosumab-biosimilars-boncresa-and-oziltus/ ... See MoreSee Less

The FDA has approved two biosimilars, increasing access to potentially life-saving medication at a potentially more cost-effective rate. Read more here: https://patientworthy.com/2026/01/08/fda-approves-amneals-denosumab-biosimilars-boncresa-and-oziltus/
View on Facebook
· Share
Share on Facebook Share on Twitter Share on Linked In Share by Email
View Comments
  • likes 0
  • Shares: 0
  • Comments: 0
Patient Worthy
16 hours ago
Patient Worthy

Results from a promising study suggest smarter breast cancer screening is on the way. Read more here:

patientworthy.com/2026/01/08/risk-based-breast-cancer-screening-shows-promise-in-major-u-s-study/ ... See MoreSee Less

Results from a promising study suggest smarter breast cancer screening is on the way. Read more here: https://patientworthy.com/2026/01/08/risk-based-breast-cancer-screening-shows-promise-in-major-u-s-study/
View on Facebook
· Share
Share on Facebook Share on Twitter Share on Linked In Share by Email
View Comments
  • likes 0
  • Shares: 0
  • Comments: 0
Load more
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy